Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
clinical trials
detroit blog main
detroit top stories
eli lilly
eptinezumab
2
×
erenumab
fda
fremanezumab
galcanezumab
2
×
indiana blog main
indiana top stories
life sciences
migraine research foundation
national
national blog main
2
×
national top stories
new york blog main
2
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alder biopharmaceutical
alder biopharmaceuticals
What
approval
class
2
×
drug
fda
migraine
new
won
amgen
arguments
big
candidates
commercialized
companies
competitors
decades
developed
drugs
gets
head
make
medicines
meeting
neuro
nod
oral
pain
potential
preventive
starts
therapies
year
Language
Current search:
eptinezumab
×
" new york blog main "
×
galcanezumab
×
" national blog main "
×
class
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines